- Report
- October 2023
- 142 Pages
Global
From €2413EUR$2,499USD£2,043GBP
- Report
- May 2024
- 128 Pages
Global
From €6275EUR$6,499USD£5,313GBP
- Report
- May 2024
- 139 Pages
Global
From €6275EUR$6,499USD£5,313GBP
- Report
- February 2024
- 175 Pages
Global
From €4828EUR$5,000USD£4,088GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1931EUR$2,000USD£1,635GBP
- Drug Pipelines
- April 2024
- 210 Pages
Global
From €2414EUR$2,500USD£2,044GBP
- Clinical Trials
- April 2024
- 450 Pages
Global
From €4828EUR$5,000USD£4,088GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1207EUR$1,250USD£1,022GBP
- Report
- March 2024
- 77 Pages
Global
From €3374EUR$3,495USD£2,857GBP
- Report
- February 2024
- 79 Pages
Global
From €6754EUR$6,995USD£5,719GBP
- Report
- August 2023
- 739 Pages
Global
From €2414EUR$2,500USD£2,044GBP
- Report
- May 2024
- 198 Pages
Global
From €3258EUR$3,374USD£2,759GBP
€3620EUR$3,749USD£3,065GBP
- Report
- March 2024
- 195 Pages
Global
From €3258EUR$3,374USD£2,759GBP
€3620EUR$3,749USD£3,065GBP
- Report
- February 2024
- 200 Pages
Global
From €4828EUR$5,000USD£4,088GBP
- Report
- February 2024
- 175 Pages
Global
From €4828EUR$5,000USD£4,088GBP
- Report
- February 2024
- 175 Pages
Global
From €4828EUR$5,000USD£4,088GBP
- Report
- March 2024
- 195 Pages
Global
From €3258EUR$3,374USD£2,759GBP
€3620EUR$3,749USD£3,065GBP
- Report
- March 2024
- 182 Pages
Global
From €3258EUR$3,374USD£2,759GBP
€3620EUR$3,749USD£3,065GBP
- Report
- March 2024
- 194 Pages
Global
From €3258EUR$3,374USD£2,759GBP
€3620EUR$3,749USD£3,065GBP
- Report
- March 2024
- 181 Pages
Global
From €3258EUR$3,374USD£2,759GBP
€3620EUR$3,749USD£3,065GBP
The Ovarian market is a segment of the Women's Health industry that focuses on the diagnosis, treatment, and prevention of ovarian diseases. It includes products and services related to the diagnosis, treatment, and prevention of ovarian cancer, ovarian cysts, and other ovarian disorders. The market also includes products and services related to fertility, contraception, and hormone replacement therapy.
The Ovarian market is driven by the increasing prevalence of ovarian diseases, the growing awareness of the importance of early diagnosis and treatment, and the increasing demand for fertility treatments. Additionally, the development of new technologies and treatments for ovarian diseases is expected to drive the market growth.
Some companies in the Ovarian market include AbbVie, AstraZeneca, Bayer, Merck, Novartis, Pfizer, and Roche. Show Less Read more